Literature DB >> 30149437

The relationship of pain on the upper extremity functions and quality of life in patients with carpal tunnel syndrome.

Müberra Tanrıverdi1, Zeynep Hoşbay1, Z Candan Algun2.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of study was researching the relationship of pain in patients with carpal tunnel syndrome on Quality of Life (QoL) and upper limb functionality.
METHODS: Demographical and physical measurements were performed by a physiotherapist. Pain levels were measured by Visuel Analog Scale at rest, on motion and in fatique, and the patients' results were recorded. Functionality levels were evaluated by 'Boston Carpal Tunnel Syndrome Questionnaire' and QoL by 'Short Form 12' (SF-12). Patients had 10 sessions of the physiotherapy and rehabilitation program. Assessments were repeated 1 month later.
RESULTS: The mean age 49.97 ± 11.15 years of 28 patients were included. While pre- and post-treatment between pain and functionality evaluation found a significant relationship (p< 0.05); there was no significant relationship in QoL (SF-12 p> 0.05).
CONCLUSIONS: As a result while we found statistical differences between pain and symptomatic status; there were no statistical differences between functionality, daily living activities and QoL. Appropriate rehabilitation programs should be taken into consideration to help patients obtain functionality, daily living activities and QoL.

Entities:  

Keywords:  Carpal tunnel syndrome; functionality; pain; physiotherapy; quality of life; rehabilitation

Mesh:

Year:  2019        PMID: 30149437     DOI: 10.3233/BMR-171097

Source DB:  PubMed          Journal:  J Back Musculoskelet Rehabil        ISSN: 1053-8127            Impact factor:   1.398


  1 in total

1.  The comparison of limited-incision versus standard-incision in treatment of carpal tunnel syndrome: A meta-analysis of randomized controlled trials.

Authors:  Gaocen Li; Lingde Kong; Ningzhao Kou; Yanxue Wang; Kunlun Yu; Jiangbo Bai; Dehu Tian
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.